Clinical aspects of Marburg hemorrhagic fever.

Masfique Mehedi, Allison Groseth, Heinz Feldmann, Hideki Ebihara
Author Information
  1. Masfique Mehedi: Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.

Abstract

Marburg virus belongs to the genus Marburgvirus in the family Filoviridae and causes a severe hemorrhagic fever, known as Marburg hemorrhagic fever (MHF), in both humans and nonhuman primates. Similar to the more widely known Ebola hemorrhagic fever, MHF is characterized by systemic viral replication, immunosuppression and abnormal inflammatory responses. These pathological features of the disease contribute to a number of systemic dysfunctions including hemorrhages, edema, coagulation abnormalities and, ultimately, multiorgan failure and shock, often resulting in death. A detailed understanding of the pathological processes that lead to this devastating disease remains elusive, a fact that contributes to the lack of licensed vaccines or effective therapeutics. This article will review the clinical aspects of MHF and discuss the pathogenesis and possible options for diagnosis, treatment and prevention.

References

  1. Expert Rev Vaccines. 2007 Feb;6(1):57-74 [PMID: 17280479]
  2. Virology. 2003 Sep 15;314(1):350-7 [PMID: 14517087]
  3. J Virol. 2004 May;78(10):5458-65 [PMID: 15113924]
  4. Viral Immunol. 2008 Sep;21(3):355-63 [PMID: 18788943]
  5. Virology. 2007 Jul 20;364(1):45-54 [PMID: 17391724]
  6. Vopr Virusol. 2001 Jan-Feb;46(1):33-7 [PMID: 11233285]
  7. PLoS Negl Trop Dis. 2011 May;5(5):e1183 [PMID: 21629730]
  8. J Virol. 2006 Oct;80(19):9659-66 [PMID: 16973570]
  9. Bull Soc Pathol Exot. 2005 Sep;98(3):205-9 [PMID: 16267962]
  10. Expert Opin Pharmacother. 2001 Aug;2(8):1317-24 [PMID: 11585000]
  11. Expert Rev Vaccines. 2008 May;7(4):417-29 [PMID: 18444889]
  12. J Biotechnol. 2000 Sep 29;83(1-2):67-76 [PMID: 11000462]
  13. Vaccine. 2008 Dec 9;26(52):6894-900 [PMID: 18930776]
  14. Virology. 1998 Nov 10;251(1):28-37 [PMID: 9813200]
  15. Bull Exp Biol Med. 2001 Jul;132(1):686-8 [PMID: 11687854]
  16. Klin Wochenschr. 1968 Apr 1;46(7):398-400 [PMID: 4971902]
  17. Dtsch Med Wochenschr. 1968 Mar 26;93(12):559-71 [PMID: 4966280]
  18. Curr Top Microbiol Immunol. 1999;235:205-17 [PMID: 9893385]
  19. J Virol Methods. 2011 Jan;171(1):310-3 [PMID: 21093485]
  20. J Virol. 2006 Jun;80(11):5168-78 [PMID: 16698997]
  21. Lancet. 1982 Apr 10;1(8276):816-20 [PMID: 6122054]
  22. Emerg Infect Dis. 2009 Aug;15(8):1171-5 [PMID: 19751577]
  23. Vopr Virusol. 1996 Sep-Oct;41(5):206-9 [PMID: 8967064]
  24. Virology. 1997 Dec 8;239(1):206-16 [PMID: 9426460]
  25. Trans R Soc Trop Med Hyg. 1969;63(3):295-302 [PMID: 5815873]
  26. Clin Vaccine Immunol. 2010 Nov;17(11):1723-8 [PMID: 20861331]
  27. N Engl J Med. 2006 Aug 31;355(9):866-9 [PMID: 16943398]
  28. Br J Exp Pathol. 1969 Aug;50(4):393-9 [PMID: 5806429]
  29. Arch Virol Suppl. 1996;11:101-14 [PMID: 8800792]
  30. Trop Doct. 2006 Jan;36(1):1-4 [PMID: 16483416]
  31. Rev Med Virol. 2010 Nov;20(6):344-57 [PMID: 20658513]
  32. Am J Trop Med Hyg. 1978 Nov;27(6):1210-5 [PMID: 569445]
  33. J Virol. 2009 Jul;83(14):7296-304 [PMID: 19386702]
  34. J Virol. 2003 Jul;77(14):7945-56 [PMID: 12829834]
  35. J Virol. 2009 Jul;83(13):6404-15 [PMID: 19369350]
  36. Vopr Virusol. 2008 Jan-Feb;53(1):39-41 [PMID: 18318136]
  37. Vestn Ross Akad Med Nauk. 2004;(11):22-4 [PMID: 15651659]
  38. J Virol. 2006 Jul;80(13):6497-516 [PMID: 16775337]
  39. Vaccine. 2003 Sep 8;21(25-26):4071-80 [PMID: 12922144]
  40. Ultrastruct Pathol. 1998 Jan-Feb;22(1):3-17 [PMID: 9491211]
  41. Antimicrob Agents Chemother. 2010 May;54(5):2152-9 [PMID: 20211898]
  42. Vopr Virusol. 1995 Jul-Aug;40(4):158-61 [PMID: 7483565]
  43. Virol J. 2007 Oct 25;4:108 [PMID: 17961252]
  44. Vet Pathol. 2010 Sep;47(5):831-51 [PMID: 20807825]
  45. J Virol. 2010 Oct;84(19):10386-94 [PMID: 20660192]
  46. FASEB J. 2006 Dec;20(14):2519-30 [PMID: 17023517]
  47. J Gen Virol. 1995 Feb;76 ( Pt 2):393-9 [PMID: 7844558]
  48. Nat Med. 2010 Sep;16(9):991-4 [PMID: 20729866]
  49. PLoS Pathog. 2009 Jul;5(7):e1000536 [PMID: 19649327]
  50. J Infect Dis. 2007 Nov 15;196 Suppl 2:S372-81 [PMID: 17940973]
  51. Lancet. 2003 Dec 13;362(9400):1953-8 [PMID: 14683653]
  52. Curr Top Microbiol Immunol. 1999;235:49-75 [PMID: 9893378]
  53. N Engl J Med. 2006 Aug 31;355(9):909-19 [PMID: 16943403]
  54. Zh Mikrobiol Epidemiol Immunobiol. 1994 May-Jun;(3):104-6 [PMID: 7941853]
  55. J Virol. 2001 Nov;75(22):11025-33 [PMID: 11602743]
  56. J Virol. 2006 Jun;80(11):5156-67 [PMID: 16698996]
  57. Jpn J Infect Dis. 2006 Oct;59(5):323-5 [PMID: 17060700]
  58. Lab Invest. 2000 Feb;80(2):171-86 [PMID: 10701687]
  59. Vopr Virusol. 1991 Sep-Oct;36(5):435-7 [PMID: 1803784]
  60. Clin Vaccine Immunol. 2008 Mar;15(3):460-7 [PMID: 18216185]
  61. Immunol Lett. 2002 Mar 1;80(3):169-79 [PMID: 11803049]
  62. Vopr Virusol. 1992 May-Jun;37(3):156-7 [PMID: 1441443]
  63. Trop Med Int Health. 2002 Oct;7(10):902-6 [PMID: 12358627]
  64. Emerg Infect Dis. 2007 Jan;13(1):73-81 [PMID: 17370518]
  65. Trans R Soc Trop Med Hyg. 1969;63(3):303-9 [PMID: 4978540]
  66. Dtsch Med Wochenschr. 1968 Mar 26;93(12):590-601 [PMID: 4966283]
  67. J Infect Dis. 2007 Nov 15;196 Suppl 2:S205-12 [PMID: 17940951]
  68. Vopr Virusol. 1997 Sep-Oct;42(5):226-9 [PMID: 9424849]
  69. Lancet. 2006 Apr 29;367(9520):1399-404 [PMID: 16650649]
  70. J Clin Virol. 2004 May;30(1):94-9 [PMID: 15072761]
  71. J Clin Microbiol. 2001 Jan;39(1):1-7 [PMID: 11136739]
  72. Trans R Soc Trop Med Hyg. 1969;63(3):310-27 [PMID: 4978541]
  73. Emerg Infect Dis. 2003 Dec;9(12):1531-7 [PMID: 14720391]
  74. Am J Trop Med Hyg. 2006 Jul;75(1):9-15 [PMID: 16837700]
  75. Clin Lab Med. 2006 Jun;26(2):345-86, viii [PMID: 16815457]
  76. MMWR Morb Mortal Wkly Rep. 2009 Dec 18;58(49):1377-81 [PMID: 20019654]
  77. J Clin Microbiol. 2002 Jul;40(7):2323-30 [PMID: 12089242]
  78. Dis Model Mech. 2009 Jan-Feb;2(1-2):12-7 [PMID: 19132113]
  79. Br J Exp Pathol. 1968 Oct;49(5):458-64 [PMID: 5727750]
  80. Dtsch Med Wochenschr. 1968 Mar 26;93(12):572-82 [PMID: 4966281]
  81. Emerg Infect Dis. 2010 Jul;16(7):1119-22 [PMID: 20587184]
  82. PLoS Pathog. 2010 Jan 15;6(1):e1000721 [PMID: 20084112]
  83. J Clin Microbiol. 2010 Jul;48(7):2330-6 [PMID: 20421440]
  84. Vestn Ross Akad Med Nauk. 1998;(3):35-8 [PMID: 9608275]
  85. J Infect Dis. 2003 Dec 1;188(11):1618-29 [PMID: 14639531]
  86. J Virol. 1996 Apr;70(4):2208-14 [PMID: 8642644]
  87. J Infect Dis. 2007 Nov 15;196 Suppl 2:S213-9 [PMID: 17940952]
  88. J Infect Dis. 2007 Nov 15;196 Suppl 2:S148-53 [PMID: 17940943]
  89. Nat Med. 2005 Jul;11(7):786-90 [PMID: 15937495]
  90. Br Med J. 1975 Nov 29;4(5995):489-93 [PMID: 811315]

Grants

  1. ZIA AI001136-01/Intramural NIH HHS

Word Cloud

Created with Highcharts 10.0.0hemorrhagicfeverMarburgMHFknownsystemicpathologicaldiseaseaspectsvirusbelongsgenusMarburgvirusfamilyFiloviridaecausesseverehumansnonhumanprimatesSimilarwidelyEbolacharacterizedviralreplicationimmunosuppressionabnormalinflammatoryresponsesfeaturescontributenumberdysfunctionsincludinghemorrhagesedemacoagulationabnormalitiesultimatelymultiorganfailureshockoftenresultingdeathdetailedunderstandingprocessesleaddevastatingremainselusivefactcontributeslacklicensedvaccineseffectivetherapeuticsarticlewillreviewclinicaldiscusspathogenesispossibleoptionsdiagnosistreatmentpreventionClinical

Similar Articles

Cited By